TBI Indication
Traumatic Brain Injury
Proof of Concept/Bench ValidationActive
Key Facts
Indication
Traumatic Brain Injury
Phase
Proof of Concept/Bench Validation
Status
Active
Company
About Hera Health Solutions
Hera Health Solutions is a private, pre-revenue biotech firm developing a tunable nanofiber-based drug delivery platform capable of sustained release from days to years. The company is advancing a pipeline of long-acting subcutaneous implants and patches, primarily in women's health and substance use disorder, through internal programs and co-development/licensing partnerships. Its strategy is to collaborate with pharmaceutical companies to reformulate existing APIs, leveraging FDA/GMP-approved materials and manufacturing for a potentially streamlined regulatory path.
View full company profileTherapeutic Areas
Other Traumatic Brain Injury Drugs
| Drug | Company | Phase |
|---|---|---|
| Presendin™ (Exenatide) | Invex Therapeutics | Preclinical |
| TBI Modeling Platform | bmseed | Research Tool |
| TV-301 | TheraVac Biologics | Preclinical |
| NA-731 | Biomed | Phase 2A |
| Fv-Hsp72 for TBI | Rubicon Biotechnology | Pre-clinical |
| TBI Treatment System | Vivonics | Development/Testing |
| Traumatic Brain Injury (TBI) Implant | Matricelf | Preclinical |